Issue Date: February 23, 2009
Divergence Raises $12 million
Divergence has raised $12 million from investors to advance its nematicide program. The St. Louis-based firm claims it has discovered the first new molecules to control plant parasitic nematodes, a class of pest that the firm says causes billions of dollars in crop loss annually and widespread disease in humans and animals. The 10-year-old biotechnology firm applies genomics and informatics to develop parasite controls. Working with Monsanto, Divergence last year completed the genome for the soybean cyst nematode and made it publicly available.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society